AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Pulse Biosciences, Inc Common Stock (DE)
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00BRBHVG7
53.02▲ 0.34 (0.65%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
52.68
Day's Range
51.47 – 55.00
52-Week Range
12.56 – 58.90
Volume
451.9K
Avg Volume
479.0K
Share Statistics
Shares Outstanding
Employees
116
Exchange
XNAS
Listed
2016-05-18
Share count as of July 31, 2026

Pulse Biosciences, Inc Common Stock (DE) (PLSE) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Pulse Biosciences, Inc Common Stock (DE) (PLSE)
What is Pulse Biosciences, Inc Common Stock (DE)'s Market Cap?
Pulse Biosciences, Inc Common Stock (DE)'s Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Enterprise Value?
Pulse Biosciences, Inc Common Stock (DE)'s Enterprise Value is $3.7B, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Price / Sales?
Pulse Biosciences, Inc Common Stock (DE)'s Price / Sales is 3191.2×, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EV / Revenue?
Pulse Biosciences, Inc Common Stock (DE)'s EV / Revenue is 3105.4×, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EV / EBITDA?
Pulse Biosciences, Inc Common Stock (DE)'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Revenue (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Revenue (TTM) is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Net Income (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Net Income (TTM) is -$80.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EBITDA?
Pulse Biosciences, Inc Common Stock (DE)'s EBITDA is -$82.0M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Diluted EPS (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Diluted EPS (TTM) is -1.12, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EBITDA Margin?
Pulse Biosciences, Inc Common Stock (DE)'s EBITDA Margin is -6921.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PLSEAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Product revenue
YoY growth————
Cost and expenses:
Cost of product revenue
Research and development
Selling, general and administrative
Total cost and expenses
% of revenue5923.0%4875.6%7014.0%23782.6%
Loss from operations
% of revenue-5823.0%-4775.6%-6914.0%-23682.6%
Other income (expense):
Interest income
Other income (expense)
Total other income
Net loss
% of revenue-5681.3%-4633.7%-6603.4%-22540.7%
Net loss per share, basic and diluted (in dollars per share)